Immune Health

Dr. M’s SPA Newsletter Audiocast Volume 12 Issue 45

Covid Update # 73:
Omicron US strains: as of October 22nd data – variants make up: BA.4.6 is 11%, BA.2.75 is 2%, BF.7 is 7%, BA.5 is 62%, BQ.1 is 9%, BQ1.1 is 7%
BA.5 is losing ground to many new Omicron variant offshoots. BF.7, BQ.1 and BQ1.1 are very interesting as they are apparently more infectious than BA.5. That is amazing.
We look at new PASC Long Covid data as well as the world of vaccine effectiveness. And much more…
Dr. M

Dr. M’s SPA Newsletter Audiocast Volume 12 Issue 39

Coronavirus Update #70 GOOD NEWS: This information is so important to help us all understand risk. Stratified risk is the only true way to measure personal risk. Let us look at some CDC data from the spring Omicron BA.1 and .2 spikes versus the fall 2021 delta wave.
Median age of hospitalization has increased from 60 years old with Delta to 64 with BA.1 and 71 with BA.2. Any underlying medical condition associated with hospitalization increased from 89% with Delta to 92% with BA.1 to 95% with BA.2 respectively. Length of hospital stay decreased from 4.8 to 3.9 to 3.3 days. ICU admission was down from 24% to 18% to 13% of admitted patients. Mechanical ventilation decreased from 14% to 8% to 6% of admitted patients. And Finally, death from 12% to 8% to 5% overall.

What we can glean from this data set is very clear. With successive SARS2 mutations coupled to increased population based exposure to virus via infection or vaccine, we are now seriously in a reduced risk state unless you are older than 65 years with a comorbid disease or younger than 65 with a serious disease. 95% of hospitalizations were related to a comorbid disease regardless of age. The other big takeaway was this: if you are in this high risk group, getting every available booster is vital to your survival based on the risk reduction data. For everybody else, the data is clear, you are ok – to boost or not to boost is up to you. But, absolutely work on your general health.

To your health,
Dr. M

Dr. M’s Women and Children First Podcast #29 – Dr. Tieraona Low Dog – Mother’s Health

A mother, wife, herbalist, educator, author, researcher, and medical doctor, Tieraona has trained hundreds of medical professionals as the Fellowship Director at the University of Arizona Center for Integrative Medicine, chaired dietary supplement expert panels for the United States Pharmacopeia, and has been appointed to numerous scientific advisory boards. In addition, she has authored best-selling books (including 4 published by National Geographic) and written over 50 peer-reviewed articles and 25 book chapters. Tieraona was appointed by the President of the United States to serve on a White House policy commission, has received many awards from academia, public health, and industry, and has lectured at over 600 conferences.

She is an incredible teacher with an equally incredible life story. In this episode, we discuss the world of maternal health as it relates to preparing for a healthy life and pregnancy setting the stage for a healthy child’s life.

I hope that you enjoy my conversation with Dr. Low Dog,

Dr. M

Dr. M’s SPA Newsletter Audiocast Volume 12 Issue 36

Biome Depletion Theory or Biota Alteration Theory
When we look at risk of disease over time in humans, we need to take stock in what was supposed to be versus what is. If we become mismatched genetically to the environment that we find ourselves in, then we will begin to suffer disease. The work of Dr. William Parker and colleagues is very fascinating here. His understanding of our immune solvency takes us back to a time when macrobes like parasites lived with us in a semi-symbiotic way. Most of them were harmless where a few were pathogenic. This matters tremendously because as we are learning, the microbes that exist within us play a major role in tuning the immune system towards tolerance and effective pathogen killing.
A lot to explore here,
Dr. M

Dr. M’s SPA Newsletter Audiocast Volume 12 Issue 33

Coronavirus Update 67

Natural infection provides a much better route to transmission protection than intramuscular systemic vaccination because of the induction of mucosal immunity via IgA and tissue resident T cells. (Tang et. al. 2022) If you can tolerate a natural infection without much morbidity, this seems to be a reasonable choice at this time. This is especially important now with the immune escaping variants of Omicron lineage and the reality of the current vaccine booster pool is lackluster in its effect on transmission. This calculus may change dramatically with a newer Omicron BA.5 specific vaccine that is in the works. And much more this week!

Dr. M

Dr. M’s Women and Children First Podcast #27 – Dr. Paul Offit – Covid Vaccines

Dr. Paul A. Offit is Director of the Vaccine Education Center and professor of pediatrics in the Division of Infectious Diseases at Children’s Hospital of Philadelphia. He is the Maurice R. Hilleman Professor of Vaccinology at the Perelman School of Medicine at the University of Pennsylvania.

Dr. Offit is an internationally recognized expert in the fields of virology and immunology, and was a member of the Advisory Committee on Immunization Practices to the Centers for Disease Control and Prevention. He is a member of the Food and Drug Administration Vaccines and Related Biological Products Advisory Committee, a member of the Institute of Medicine and co-editor of the foremost vaccine text, Vaccines.

He is a scientist, a skeptic, a thinker and an individual deeply passionate about children’s health.

This week we sit down to discuss Covid, vaccines and children’s health.

I hope that you enjoy my conversation with Dr. Offit,

 

Dr. M

Dr. M’s SPA Newsletter Audiocast Volume 12 Issue 31

Coronavirus Update #66

This week is another close look at the current variants of the Omicron lineage, especially BA.5. What is the deal with this strain? Is it causing more heart ache in the United States or just an annoying highly infectious variant? In my opinion, when we have global flairs of Covid 19, there is clear evidence now that individuals that are immune compromised have unwittingly become breeding grounds for genomic mutations in SARS2 leading to variants of concern. These variants become our new circulating troublemakers. Thus, in my opinion, we should be making vaccines in this country that are high quality and targeted to the current strain. Then we should be releasing it worldwide very quickly to people in immune compromised states. This should have the effect of slowing down these emerging VOC’s that are evading our natural and vaccine induced immunity. Finally, we end with a discussion of chronic rhino sinusitis.

Enjoy,

Dr. M